Ticker
AADI

Price
1.51
Stock movement up
+0.08 (5.59%)
Company name
Aadi Bioscience Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
37.08M
Ent value
3.91M
Price/Sales
1.56
Price/Book
0.41
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
37.40%
1 year return
-74.23%
3 year return
-84.98%
5 year return
-61.84%
10 year return
-
Last updated: 2024-07-22

DIVIDENDS

AADI does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.56
Price to Book0.41
EV to Sales0.16

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count24.55M
EPS (TTM)-2.55
FCF per share (TTM)-2.27

Income statement

Loading...
Income statement data
Revenue (TTM)23.84M
Gross profit (TTM)20.91M
Operating income (TTM)-74.62M
Net income (TTM)-68.83M
EPS (TTM)-2.55
EPS (1y forward)-2.86

Margins

Loading...
Margins data
Gross margin (TTM)87.70%
Operating margin (TTM)-313.00%
Profit margin (TTM)-288.72%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash53.78M
Net receivables4.93M
Total current assets102.57M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment7.08M
Total assets111.07M
Accounts payable3.10M
Short/Current long term debt6.92M
Total current liabilities19.88M
Total liabilities20.61M
Shareholder's equity90.46M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-58.01M
Capital expenditures (TTM)3.34M
Free cash flow (TTM)-61.35M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-76.09%
Return on Assets-61.97%
Return on Invested Capital-71.22%
Cash Return on Invested Capital-63.48%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.47
Daily high1.53
Daily low1.42
Daily Volume58K
All-time high1485.00
1y analyst estimate11.00
Beta0.35
EPS (TTM)-2.55
Dividend per share-
Ex-div date-
Next earnings date7 Aug 2024

Downside potential

Loading...
Downside potential data
AADIS&P500
Current price drop from All-time high-99.90%-1.81%
Highest price drop-99.91%-56.47%
Date of highest drop2 Jul 20249 Mar 2009
Avg drop from high-80.87%-11.26%
Avg time to new high90 days12 days
Max time to new high1671 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
AADI (Aadi Bioscience Inc) company logo
Marketcap
37.08M
Marketcap category
Small-cap
Description
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Employees
75
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...